Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Raymond James Maintains Outperform on Knight-Swift, Raises Price Target to $55

Raymond James analyst Felix Boeschen maintains Knight-Swift (NYSE:KNX) with a Outperform and raises the price target from $53 to $55.
byBenzinga Newsdesk
July 21, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Raymond James analyst Felix Boeschen maintains Knight-Swift (NYSE:KNX) with a Outperform and raises the price target from $53 to $55.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Ambrx Announces ARX517, A PSMA-Targeted ADC, Demonstrates 52% PSA50 (≥50% Reduction) And A Highly Differentiated Safety And PK Profile In Patients With mCRPC, Who Progressed On Multiple FDA-Approved Treatments

By Happy Mohamed
October 23, 8:10 AM
Newly published data from the Phase 1 portion of the on-going Phase 1 / 2 APEX-01 trial provide the following key points: Multiple efficacy endpoints demonstrate consistent and promising anti-cancer activity at

AMAM